Showing 36,902 results

Government, leadership & policy

Only 3 Presidential Candidates Share How They Will Address HIV

Editor's pick
HIVPlus
1 February 2016
New & experimental hepatitis C treatment

Zepatier for hepatitis C approved in Canada

Editor's pick
CATIE
1 February 2016
Treatment outcomes & life expectancy

Haitian AIDS Patients' 10-year Survival Equal to American Patients

Editor's pick
Weill Cornell Medical College
1 February 2016
Hepatitis C treatment

European Commission Approves Daklinza (daclatasvir) for the Treatment of Genotype 1, 3 and 4 Chronic Hepatitis C Patients with HIV Coinfection, Advanced Cirrhosis and Post-liver Transplant Recurrence of HCV

Editor's pick
Bristol-Myers Squibb press release
1 February 2016
Dating, relationships & feelings

How to Talk to Your Partner About Going on PrEP

Editor's pick
HIV Plus
1 February 2016
Undetectable viral load & treatment as prevention

HIV is not transmitted under fully suppressive therapy: The Swiss Statement – eight years later

Editor's pick
Swiss Medical Weekly
30 January 2016
Infant feeding

For African women with HIV, not breastfeeding is not easy

Editor's pick
Reuters
29 January 2016
Hepatitis C treatment

Merck Prices Hepatitis C Drug Lower Than Rivals in Crowded Field

Editor's pick
Bloomberg
29 January 2016
New & experimental hepatitis C treatment

Merck Receives FDA Approval of ZEPATIER™ (elbasvir and grazoprevir) for the Treatment of Chronic Hepatitis C Virus Genotype 1 or 4 Infection in Adults

Editor's pick
Merck press release
29 January 2016
Resistance

HIV resistance to favored treatment not uncommon

Editor's pick
Reuters
29 January 2016
PrEP

Why don’t we give this HIV pill to those most at risk?

Editor's pick
Dazed
28 January 2016
Pharmaceutical industry

Gilead Faces Fights Over Hepatitis C and H.I.V. Drugs

Editor's pick
New York Times
28 January 2016
The search for a cure

HIV protein manipulates hundreds of human genes to advance progression into AIDS, study shows

Editor's pick
UT Southwestern Medical Center
28 January 2016
Pharmaceutical industry

Massachusetts official challenges Gilead's hepatitis C drug prices

Editor's pick
Reuters
28 January 2016
The search for an HIV prevention vaccine

About that latest big Gates Foundation bet for HIV prevention

Editor's pick
Inside Philanthropy
27 January 2016
New & experimental HIV treatments

CytoDyn Announces HIV-Patients Approaching 17 Months of Complete Viral Suppression With PRO 140 Monotherapy

Editor's pick
Cytodyn Inc.
27 January 2016
Global health initiatives

PEPFAR's Dr Deborah Birx urges sharper focus to halt HIV globally

Editor's pick
Fogarty International Center
27 January 2016
Pharmaceutical industry

AHF Files Federal Lawsuit Against Gilead to Invalidate Patents on Key AIDS Drug

Editor's pick
AIDS Healthcare Foundation
27 January 2016
Contraception

The Latest Study on Depo-Provera and HIV: Far More Complex Than Most Headlines Suggest

Editor's pick
RH Reality Check
27 January 2016
HIV prevention policy

The Kremlin Shows the World How to Make an AIDS Crisis Worse

Editor's pick
Newsweek
27 January 2016
New & experimental HIV treatments

Experimental Combination Surprises with Anti-HIV Effectiveness

Editor's pick
National Institute of Mental Health
27 January 2016
UK health services

Infected blood: reform of financial and other support

Editor's pick
Department of Health
26 January 2016
Harm reduction

UNGASS Without Harm Reduction? No Way!

Editor's pick
Drug Reporter
26 January 2016
Harm reduction

HRI has serious concerns with draft UNGASS outcome document

Editor's pick
Harm Reduction International
26 January 2016